Dynasplint Systems, Inc.
15
0
0
3
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 100/100
60.0%
9 terminated/withdrawn out of 15 trials
25.0%
-61.5% vs industry average
7%
1 trials in Phase 3/4
33%
1 of 3 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (15)
Dynasplint Therapy for Trismus in Head and Neck Cancer
Role: collaborator
Contracture Reduction Following Bunionectomy: a Longitudinal, Controlled Trial
Role: lead
Dynamic Splinting After Total Knee Arthroplasty
Role: lead
Dynamic Splinting for Plantarflexion in Spastic Hemiplegia
Role: lead
Dynamic Splinting for Patients With Adhesive Capsulitis
Role: lead
Toe Walker Gait Trial
Role: lead
Dynamic and Static Splinting as a Treatment for Plantar Faciiopathy
Role: lead
Adhesive Capsulitis and Dynamic Splinting
Role: lead
Ankle Equinus Contracture Treated With Dynamic Splinting
Role: lead
Dynasplint for Distal Radius Fracture
Role: lead
Dynamic Splinting for Excessive Pronation Following CVA
Role: lead
Wrist Extension Dynasplint (WED) Distal Radius Fracture
Role: lead
Plantar Fasciitis Treated With Dynamic Splinting
Role: lead
Hallux Limitus Treated With Dynamic Splinting: A Randomized, Controlled Trial
Role: lead
Treatment of Carpal Tunnel Syndrome With Dynamic Splinting
Role: collaborator
All 15 trials loaded